-
1.
Pregnant or nursing patients
-
2.
Any myocardial infarction at index presentation or within 90 d prior to enrollment, defined as any electrocardiogram diagnostic for myocardial infarction OR elevation in serum troponin greater than the upper limit of the site-defined reference range
-
3.
Known LVEF <50% or cardiogenic shock requiring pressors or mechanical circulatory assistance (eg, intra-aortic balloon pump, left ventricular assist device, other temporary cardiac support blood pump)
-
4.
Renal insufficiency, defined as estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 (by the Modification of Diet in Renal Disease equation) or dialysis at the time of screening
-
5.
Prior percutaneous coronary intervention
-
6.
Planned percutaneous coronary intervention (PCI)
-
7.
Prior coronary artery bypass graft surgery
-
8.
Prior ST-elevation myocardial infarction
-
9.
History of hypertrophic cardiomyopathy
-
10.
History of infiltrative heart disease (eg, cardiac amyloidosis)
-
11.
New York Heart Association Class IV congestive heart failure
-
12.
Severe mitral regurgitation
-
13.
Severe aortic stenosis
-
14.
Severe pulmonary hypertension (mean pulmonary artery pressure ≥35 mm Hg or echocardiographic right ventricular systolic pressure ≥60 mm Hg)
-
15.
Known history of unrepaired or repaired congenital heart disease
-
16.
Past or pending heart transplant, or on the waiting list for organ transplant
-
17.
Known other medical illness or known history of substance abuse that may cause noncompliance with the protocol, or is associated with a life expectancy of less than 1 year
-
18.
Current or planned participation in a study of an investigational therapy